Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Treatment of left ventricular assist device-associated arteriovenous malformations with thalidomide.

Ray R, Kale PP, Ha R, Banerjee D.

ASAIO J. 2014 Jul-Aug;60(4):482-3. doi: 10.1097/MAT.0000000000000087.

PMID:
24830804
2.

Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device.

Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH.

J Heart Lung Transplant. 2005 Jan;24(1):105-9.

PMID:
15653390
3.

Novel Use of Thalidomide in Recurrent Gastrointestinal Tract Bleeding in Patients with Left Ventricular Assist Devices: A Case Series.

Chan LL, Lim CP, Lim CH, Tan TE, Sim D, Sivathasan C.

Heart Lung Circ. 2017 Oct;26(10):1101-1104. doi: 10.1016/j.hlc.2016.11.017. Epub 2016 Dec 23.

PMID:
28131776
4.

Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device.

Demirozu ZT, Radovancevic R, Hochman LF, Gregoric ID, Letsou GV, Kar B, Bogaev RC, Frazier OH.

J Heart Lung Transplant. 2011 Aug;30(8):849-53. doi: 10.1016/j.healun.2011.03.008. Epub 2011 Apr 29.

PMID:
21530318
5.

Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.

John R, Kamdar F, Liao K, Colvin-Adams M, Miller L, Joyce L, Boyle A.

J Thorac Cardiovasc Surg. 2008 Nov;136(5):1318-23. doi: 10.1016/j.jtcvs.2007.12.077. Epub 2008 Sep 14.

6.

Left ventricular assist devices and gastrointestinal bleeding: a narrative review of case reports and case series.

Islam S, Cevik C, Madonna R, Frandah W, Islam E, Islam S, Nugent K.

Clin Cardiol. 2013 Apr;36(4):190-200. doi: 10.1002/clc.22096. Epub 2013 Feb 3. Review.

7.

Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?

Rennyson SL, Shah KB, Tang DG, Kasirajan V, Pedram S, Cahoon W, Malhotra R.

ASAIO J. 2013 Jul-Aug;59(4):450-1. doi: 10.1097/MAT.0b013e318295232d.

PMID:
23820288
8.

Association of Nasal Mucosal Vascular Alterations, Gastrointestinal Arteriovenous Malformations, and Bleeding in Patients With Continuous-Flow Left Ventricular Assist Devices.

Patel SR, Madan S, Saeed O, Algodi M, Luke A, Gibber M, Goldstein DJ, Jorde UP.

JACC Heart Fail. 2016 Dec;4(12):962-970. doi: 10.1016/j.jchf.2016.08.005. Epub 2016 Oct 12.

9.

Inhaled Desmopressin for Refractory Gastrointestinal Bleeding in a Patient With a HeartMate II Left Ventricular Assist Device.

Hollis IB, Chen SL, Chang PP, Katz JN.

ASAIO J. 2017 Jul/Aug;63(4):e47-e49. doi: 10.1097/MAT.0000000000000433.

PMID:
27556142
10.

Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation.

Ge ZZ, Chen HM, Gao YJ, Liu WZ, Xu CH, Tan HH, Chen HY, Wei W, Fang JY, Xiao SD.

Gastroenterology. 2011 Nov;141(5):1629-37.e1-4. doi: 10.1053/j.gastro.2011.07.018. Epub 2011 Jul 22.

PMID:
21784047
11.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
12.

Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices.

Houston BA, Schneider AL, Vaishnav J, Cromwell DM, Miller PE, Faridi KF, Shah A, Sciortino C, Whitman G, Tedford RJ, Stevens GR, Judge DP, Russell SD, Rouf R.

J Heart Lung Transplant. 2017 Apr;36(4):380-385. doi: 10.1016/j.healun.2016.12.016. Epub 2016 Dec 30.

PMID:
28169115
13.

Successful treatment with thalidomide of a patient with congenital factor V deficiency and factor V inhibitor with recurrent gastrointestinal bleeding from small bowel arteriovenous malformations.

Perez Botero J, Burns D, Thompson CA, Pruthi RK.

Haemophilia. 2013 Jan;19(1):e59-61. doi: 10.1111/hae.12066. Epub 2012 Nov 22. No abstract available.

PMID:
23171429
14.

Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.

Stulak JM, Lee D, Haft JW, Romano MA, Cowger JA, Park SJ, Aaronson KD, Pagani FD.

J Heart Lung Transplant. 2014 Jan;33(1):60-4. doi: 10.1016/j.healun.2013.07.020. Epub 2013 Sep 7.

PMID:
24021944
15.

Use of left ventricular assist device (HeartMate II): a Singapore experience.

Lim CP, Sivathasan C, Tan TE, Lim CH, Kerk KL, Sim DK.

Artif Organs. 2014 Jul;38(7):543-8. doi: 10.1111/aor.12247. Epub 2014 Jan 7.

PMID:
24392937
16.

Severe upper gastrointestinal bleeding in Heartmate II induced by acquired von Willebrand deficiency: anticoagulation management.

Sponga S, Nalli C, Casonato A, Charbonneau E.

Ann Thorac Surg. 2012 Aug;94(2):e41-3. doi: 10.1016/j.athoracsur.2012.01.087. Epub 2012 May 11.

PMID:
22579885
17.

[Thalidomide associated to endoscopic treatment with argon plasma coagulation in rectal bleeding caused by vascular injury secundary to severe actinic proctitis].

Pizarro Moreno A, Garzón Benavides M, Araujo Miguez A, Bozada García JM.

Med Clin (Barc). 2012 Oct 6;139(8):369-70. doi: 10.1016/j.medcli.2012.02.005. Epub 2012 Apr 10. Spanish. No abstract available.

PMID:
22498348
18.
19.

Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.

Bauditz J.

World J Gastroenterol. 2016 Mar 21;22(11):3158-64. doi: 10.3748/wjg.v22.i11.3158. Review.

20.

Gastrointestinal bleeding after continuous-flow left ventricular device implantation: review of pathophysiology and management.

Guha A, Eshelbrenner CL, Richards DM, Monsour HP Jr.

Methodist Debakey Cardiovasc J. 2015 Jan-Mar;11(1):24-7. doi: 10.14797/mdcj-11-1-24. Review.

Supplemental Content

Support Center